Immuno-PET imaging for non-invasive assessment of cetuximab accumulation in non-small cell lung cancer

BACKGROUNDS: Overexpression of epidermal growth factor receptor (EGFR) has been established as a valid therapeutic target of non-small cell lung cancer (NSCLC). However, the clinical benefit of cetuximab as an EGFR-targeting drug is still controversial, partially due to the lack of effective means t...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:BMC Cancer
Autors principals: Yamaguchi, Aiko, Achmad, Arifudin, Hanaoka, Hirofumi, Heryanto, Yusri Dwi, Bhattarai, Anu, Ratianto, Khongorzul, Erdene, Shintawati, Rini, Kartamihardja, A. Adhipatria P., Kanai, Ayaka, Sugo, Yumi, S. Ishioka, Noriko, Higuchi, Tetsuya, Tsushima, Yoshito
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2019
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6813975/
https://ncbi.nlm.nih.gov/pubmed/31651282
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-019-6238-4
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars